Monthly Prescribing Reference

Advair Diskus 500/50

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...
RAPS

Mylan Wins FDA Approval for First Advair Generic

The US Food and Drug Administration (FDA) late Wednesday approved the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the ...
MarketWatch

Glaxo: FDA OKs expanded use of Advair Diskus lung disease drug

GlaxoSmithKline's GSK treatment to reduce exacerbations in chronic obstructive pulmonary disease patients was approved by the U.S. Food and Drug Administration. The Research Triangle park, N.C., ...
Reuters

Glaxo wins U.S. FDA approval for wider Advair use

WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...